Fundraising Fox株式会社メドレックス
Higashikagawa, Kagawa, JP · Founded 2002 · 2 known investors
Find your way into 株式会社メドレックス
Sign up to see every warm intro you have to 株式会社メドレックス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社メドレックス team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
Founders & leadership
YM
Yonehiro MatsumuraRepresentative Director & President
松米
松村 米浩代表取締役社長
Investors · 2
Nippon Venture Capitallisted by Nippon Venture CapitalTokyo · $300K – $5M
How we know: Nippon Venture Capital's portfolio page · Not right? Tell us
SMBC Venture Capitallisted by SMBC Venture CapitalTokyovia Hiroya Ota · inferred
How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does 株式会社メドレックス do?
- MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
- Who are 株式会社メドレックス's investors?
- 株式会社メドレックス's investors include Nippon Venture Capital, SMBC Venture Capital.
- Where is 株式会社メドレックス headquartered?
- 株式会社メドレックス is headquartered in Higashikagawa, Kagawa, JP.